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Introduction
ADA2 deficiency, a recently described disease, is charac-
terized by systemic vasculopathy and episodes of
strokes. The defect is due to a loss of function mutation
of CECR1 gene, codifying for Adenosine Deaminase
2 protein. This protein regulates the catabolism of extra-
cellular adenosine, which we have recently shown is an
important regulator of Class Switch Recombination in B
lymphocytes. Accordingly DADA2 patients can present
hypogammaglobulinemia.
Objectives
Therefore we decided to characterize peripheral B and
T lymphocytes of DADA patients to directly address if
ADA2 mutation affects B-cell function and in particular
we focused on B cell- T cell interaction.
Patients and methods
3 patients carrying mutations in CECR1 were examined.
They showed clinical history with livedo reticularis, fever,
vasculitis and neurological symptoms. Two patients pre-
sented hypogammaglobulinemia requiring intravenous
immunoglobulin replacement therapy. We analyzed per-
ipheral B and T cell phenotype by flow cytometry, in vitro
B-cell proliferation and differentiation to Immunoglobulin
secreting cells in response to CpG and T cell help.
Results
Flow cytometer analysis showed a reduction of total
B cells compared with age matched controls. Intriguingly
a decrease in the percentage of memory B cell compart-
ment (CD19+CD27+) was observed. Moreover we noted
that the rate of B cells proliferation and differentiation to
Immunoglobulin Secreting Cells of DADA2 patients with
autologous T cell help are impaired. In fact in vitro IgM,
IgG and IgA secretion is significantly reduced with
respect to HD B lymphocytes in presence of mutated
CD4 helper T cells.
Conclusions
Our findings suggest that ADA2 defect could lead to a
defect in B cell function and to a reduced T cell dependent
B cell response.
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